SALARIUS PHARMACEUTICALS INC (SLRX)
US79400X4043 - Common Stock
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 3.28M | 5.90M | 12.11M | 29.21M | 11.12M | |||
| Marketable Securities | N/A | N/A | N/A | N/A | N/A | |||
| Receivables | N/A | 0.00 | 1.61M | 0.00 | 3.86M | |||
| Inventories | N/A | N/A | N/A | N/A | N/A | |||
| Other Current Assets | 538.62K | 619.76K | 800.00K | 950.00K | 820.00K | |||
| Total Current Assets | 3.82M | 6.52M | 14.52M | 30.16M | 15.80M | |||
| Non-Current Assets | ||||||||
| PPE Net | N/A | N/A | N/A | 10.00K | 20.00K | |||
| Investments And Advances | N/A | N/A | N/A | N/A | N/A | |||
| Goodwill | N/A | N/A | 0.00 | 8.87M | 8.87M | |||
| Other Non-Current Assets | 36.52K | 66.85K | 130.00K | 190.00K | 250.00K | |||
| Total Non-Current Assets | 36.51K | 66.85K | 130.00K | 10.67M | 9.13M | |||
| TOTAL ASSETS | 3.86M | 6.59M | 14.65M | 40.83M | 24.93M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 328.85K | 289.64K | 0.00 | 0.00 | 480.00K | |||
| Accrued Expenses | 439.93K | 406.75K | 1.41M | 550.00K | 380.00K | |||
| Accounts Payable | 165.80K | 602.85K | 2.86M | 1.54M | 1.85M | |||
| Other Current Liabilities | N/A | N/A | N/A | 10.00K | 60.00K | |||
| Total Current Liabilities | 934.58K | 1.30M | 4.27M | 2.11M | 2.77M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | N/A | N/A | N/A | N/A | N/A | |||
| Total Non-Current Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| TOTAL LIABILITIES | 934.58K | 1.30M | 4.27M | 2.11M | 2.77M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -80.46M | -76.35M | -63.81M | -32.20M | -19.43M | |||
| Additional Paid In Capital | 83.38M | 81.63M | 74.19M | 70.92M | 41.59M | |||
| Common Shares | 140.00 | 390.00 | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | N/A | N/A | N/A | N/A | N/A | |||
| Shares Outstanding | 1.44M | 492.30K | 2.26M | 1.81M | 950.00K | |||
| Tangible Book Value per Share | 2.03 | 10.74 | 4.59 | 16.49 | 13.99 | |||
| Total Shareholders' Equity | 2.92M | 5.29M | 10.38M | 38.72M | 22.16M | |||
| TOTAL LIABILITIES AND EQUITY | 3.86M | 6.59M | 14.65M | 40.83M | 24.93M | |||
| Statistics | ||||||||
| Current Ratio | 4.09 | 5.02 | 3.40 | 14.29 | 5.70 | |||
| Return On Assets (ROA) | -129.40% | -190.43% | -215.77% | -31.28% | -31.09% | |||
| Return On Equity (ROE) | -170.75% | -237.22% | -304.53% | -32.98% | -34.97% | |||
All data in USD , ROIC based on taxRate of 0.21